ClinicalTrials.govpublic full text
Sequencing of Radium-223 and Docetaxel in Symptomatic Bone-only Metastatic Castration-resistant Prostate Cancer
metastatic castration-resistant prostate cancer, prostate cancer, castration-resistant prostate cancer, metastatic prostate cancer, bone only metastatic prostate cancer, radium-223, docetaxel, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 842155
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.